Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial
PaperCitations, authors & open-access status
Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 108 citations, 2023 year and gold oa status.
108
Citations
2023
Year
gold
OA Status